Vitamin D Supplementation in Psychiatric Illnesses
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Children and adolescents with psychiatric illnesses who are treated with medications called
second generation antipsychotic agents (SGA) often gain excessive weight during their
treatment with these medications. This weight gain may result in the development of features
of the metabolic syndrome or frank diabetes mellitus. There is no consensus on the best way
to prevent these complications. The investigators' hypothesis is that daily vitamin D
supplementation in these patients will result in decreased levels of the markers of metabolic
syndrome with associated reduction in waist circumference.